Unknown

Dataset Information

0

Perphenazine Attenuates the Pro-Inflammatory Responses in Mouse Models of Th2-Type Allergic Dermatitis.

ABSTRACT: Developing dermatitis therapeutics has been faced with challenges including adverse effects of topical steroid and high cost of new developing drugs. Here, we found the expression levels of dopamine receptor D2 is higher in skin biopsies of dermatitis patients and an oxazolone-induced animal model of dermatitis. We used perphenazine, an FDA-approved dopamine receptor antagonist to determine the therapeutic effect. Two different animal models including 12-o-tetradecanoylphorbol-13-acetate (TPA) and oxazolone (OXA)-induced dermatitis were employed. TPA and OXA-mediated ear swelling was attenuated by perphenazine. Moreover, perphenazine inhibited infiltrated mast cells into lesion area. We found levels of serum IgE, histamine and cytokines are decreased in mice cotreated with perphenazine and OXA compared to OXA-treated mice. Overall, this is a first study showing that the FDA-approved, anti-psychotic drug, perphenazine, alleviates animal models of dermatitis.

SUBMITTER: Heo MJ 

PROVIDER: S-EPMC7247351 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Perphenazine Attenuates the Pro-Inflammatory Responses in Mouse Models of Th2-Type Allergic Dermatitis.

Heo Min-Jeong MJ   Choi Soo Young SY   Lee Chanmi C   Choi Yeong Min YM   An In-Sook IS   Bae Seunghee S   An Sungkwan S   Jung Jin Hyuk JH  

International journal of molecular sciences 20200503 9

Developing dermatitis therapeutics has been faced with challenges including adverse effects of topical steroid and high cost of new developing drugs. Here, we found the expression levels of dopamine receptor D2 is higher in skin biopsies of dermatitis patients and an oxazolone-induced animal model of dermatitis. We used perphenazine, an FDA-approved dopamine receptor antagonist to determine the therapeutic effect. Two different animal models including 12-o-tetradecanoylphorbol-13-acetate (TPA) a  ...[more]

Similar Datasets

Unknown RGS16 attenuates pulmonary Th2/Th17 inflammatory responses.
| S-EPMC3522182 | biostudies-other
Unknown TRPM8 activation attenuates inflammatory responses in mouse models of colitis.
| S-EPMC3645521 | biostudies-other
Unknown Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy.
| S-EPMC3208064 | biostudies-literature
Unknown Mahuang Fuzi Xixin Decoction Attenuates Th1 and Th2 Responses in the Treatment of Ovalbumin-Induced Allergic Inflammation in a Rat Model of Allergic Rhinitis.
| S-EPMC5530432 | biostudies-other
Unknown Leptin Enhances TH2 and ILC2 Responses in Allergic Airway Disease.
| S-EPMC5063987 | biostudies-literature
Unknown Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions.
| S-EPMC8022127 | biostudies-literature
Unknown Th2 and eosinophil responses suppress inflammatory arthritis.
| S-EPMC4899615 | biostudies-literature
Unknown Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis.
| S-EPMC2929900 | biostudies-other
Unknown Genomic responses in mouse models greatly mimic human inflammatory diseases.
| S-EPMC4313832 | biostudies-other
Unknown IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses.
| S-EPMC4083497 | biostudies-literature